About Genomate Health

Genomate - the world’s first AI-powered clinical decision support that matches targeted therapies to the totality of available molecular information for each patient

Welcome to
Genomate Health

the company behind world's first AI-powered clinical decision support system for precision oncology. We are a team of experienced professionals in oncology, AI, and business dedicated to revolutionizing cancer treatment by providing personalized care to every patient. We are a spin-out and partner company of Oncompass Medicine, located in Budapest, Hungary.

We are proud to have transformed the lives of countless cancer patients, providing hope and better outcomes. Genomate can help predict patients who are not likely to benefit from a drug and should get another treatment.

Our story

Genomate Health was founded with a clear vision: to revolutionize cancer treatment through personalized medicine. Our journey began with a passionate team of doctors and scientists who recognized the need for innovative solutions in oncology.

We embarked on a comprehensive research and development journey that spanned several decades. Our dedicated team worked tirelessly to refine our AI algorithms and create the Genomate platform, laying the foundation for a new era in cancer care.

Abstract picture of cancer tumour by Genomate Health

2003

2015

2019

2021

2022

2023

Founding of Oncompass Medicine Hungary Kft

Oncompass was founded in 2003 by two physicians, Istvan Petak and Richard Schwab, with a special background in molecular pharmacology and pathology

First successful personalized treatment

First successful personalized treatment with targeted therapy of a lung cancer patient the world published in Journal of Clinical Oncology in the US.

Registration and utilization of the first AI tool for precision oncology

Breakthrough Innovations (AI) in Oncology Conference Award at ASCO 2019

Future Unicorn Award of the DIGITALEUROPE and the EU Commission for the most promising European technology company.

Global Champion of the GET-IN-THE-RING global startup competition out of 25,000 applicants of 109 countries, from all fields and industries.

Landmark publication in Nature’s NPJ Precision Oncology

introducing the first clinically proven AI tool for personalized treatment decisions in precision medicine.

Genomate Health is a founding member of CancerX

White House initiative, to empower oncologists with technology in the battle against cancer

We have received prestigious awards and accolades for our innovative approach and dedication to advancing precision oncology.

Future Unicorn Award: Most promising
technology company in Europe

DIGITALEUROPE,
2021 edition

Breakthrough Innovations (AI) in Oncology Conference Award 2019

AMERICAN SOCIETY OF
CLINICAL ONCOLOGY

AMERICAN SOCIETY OF CLINICAL ONCOLOGY

Global Champion
109 countries, 25,000 applicants

GET IN THE RINGSTART-UP
COMPETITION IN 2021

Our Vision & Values

Our vision

A world where every patient receives the right treatment. The first time. Everytime.

We’re pioneers

We lead the way into a world where every patient has the right treatment.

We’re modern craftsmen

Everything we build is based on multidisciplinary expertise.

We’re reliable

Everything we do is backed by years of scientific research.

We’re quality-driven

Our scientific methods, professionalism and ethics cannot be questioned.

Our Vision:

A world where every patient receives the right treatment.
The first time. Every time.

We’re pioneers:

We lead the way into a world where every patient has the right treatment.

We’re reliable:

Everything we do is backed by years of scientific research.

We’re modern craftsmen:

Everything we build is
based on multidisciplinary expertise.

We’re quality-driven:

Our scientific methods, professionalism and ethics cannot be questioned.

Our ambition extends beyond borders

We are at the forefront of advancements in precision oncology. As technology evolves, we continuously refine and expand the capabilities of our platform to provide increasingly accurate and targeted treatment recommendations.

We are actively expanding our reach to collaborate with healthcare providers and oncologists worldwide, ensuring that patients worldwide can benefit from the transformative power of Genomate and Genomate Health.

US-based. Helping the world.

We are actively expanding our reach to collaborate with healthcare providers and oncologists worldwide, ensuring that patients can benefit from the transformative power of Genomate.

Future Unicorn Award: Most promisingtechnology company in Europe

Breakthrough Innovations (AI) in Oncology Conference Award 2019

Global Champion109 countries, 25,000 applicants

Future Unicorn Award: Most promising
technology company in Europe

Global Champion
109 countries, 25,000 applicants